Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of in Vivo Cultured Limbal Stem Cells in the Treatment of Unilateral Corneal Stem Cell Damage

NCT02649621 is registered in ClinicalTrials.gov with Royan Institute as lead sponsor.

NCT NCT02649621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02649621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of in Vivo Cultured Limbal Stem Cells in the Treatment of Unilateral Corneal Stem Cell Damage
Lead sponsor
Royan Institute
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2011
Completion date
August 31, 2012
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

limbal stem cell deficiency (lscd)